APA (7th ed.) Citation

R, G., N, D., A, T., A, M., S, C., E, T., . . . MB, C. (2019). A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma. Haematologica, 104(1), 138. https://doi.org/10.3324/haematol.2018.191429

Chicago Style (17th ed.) Citation

R, Gressin, et al. "A Phase 2 Study of Rituximab, Bendamustine, Bortezomib and Dexamethasone for First-line Treatment of Older Patients with Mantle Cell Lymphoma." Haematologica 104, no. 1 (2019): 138. https://doi.org/10.3324/haematol.2018.191429.

MLA (9th ed.) Citation

R, Gressin, et al. "A Phase 2 Study of Rituximab, Bendamustine, Bortezomib and Dexamethasone for First-line Treatment of Older Patients with Mantle Cell Lymphoma." Haematologica, vol. 104, no. 1, 2019, p. 138, https://doi.org/10.3324/haematol.2018.191429.